Roel C A Achterbergh1, Henry J C de Vries1,2, Anders Boyd3,4, Udi Davidovich3, Susanne Drückler1, Elske Hoornenborg3, Maria Prins3,5, Amy Matser3. 1. STI Outpatient Clinic, Department Of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, the Netherlands. 2. Department of Dermatology, Amsterdam Institute for Infection and Immunity (AI and II), Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. 3. Research and Prevention, Department of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, the Netherlands. 4. Institut Pierre Louis d'Épidémiologie et de Santé Publique, INSERM, Sorbonne Université, Paris, France. 5. Department of Infectious Diseases, Amsterdam Institute for Infection and Immunity (AI and II), Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Abstract
BACKGROUND AND AIMS: Men who have sex with men (MSM) are at high risk for both drug use and sexually transmitted infections (STI). We aimed to (1) identify subgroups of drug use during sex among MSM in Amsterdam and after classifying participants and (2) compare sexual behaviour and STI across groups. DESIGN: Cross-sectional study. Latent class analysis was used to identify subgroups with similar drug use patterns, between which sexual behaviour and STI prevalence were compared. SETTING: Four different studies conducted at the STI out-patient clinic in Amsterdam, the Netherlands, between January 2014 and June 2016. PARTICIPANTS: A total of 1130 self-declared MSM, aged ≥ 18 years. MEASUREMENTS: Self-reported drug use, laboratory-confirmed STI, socio-demographics, sexual behaviour (including number of partners), condom use. FINDINGS: Median age was 40 years [interquartile range (IQR) = 32-47]. We identified five latent classes of users, which we labelled: 'no substance' (n = 162), 'alcohol' (n = 159), 'nitrites and erectile dysfunction drugs (EDD)' (n = 286), 'polydrug' (n = 257) and 'chems' (n = 266). Median number of sex partners significantly differed across classes (P < 0.001), ranging from two (IQR = 1-6) in the 'no substance' class to 20 (IQR = 10-45) in the 'chems' class. The proportion of MSM reporting condomless anal sex also differed across classes (P < 0.001), ranging from 45.6% in the 'no substance' class to 86.5% in the 'chems' class. Compared with the 'no substance' class, the odds of STI were 3.9-fold [95% confidence interval (CI) = 1.1-14.4] higher in the 'alcohol' class, 8.9-fold (95% CI = 2.7-29.2) higher in the 'nitrites and EDD' class, 12.8-fold (95% CI = 3.9-41.9) higher in the 'polydrug' class and 15.0-fold (95% CI = 4.6-48.8) higher in the 'chems' class. CONCLUSION: There are five distinct classes of drug use in a sexual context among men who have sex with men in Amsterdam, the Netherlands. Classes with higher levels of drug use appear to coincide with higher levels of sexual risk behaviour and sexually transmitted infections.
BACKGROUND AND AIMS: Men who have sex with men (MSM) are at high risk for both drug use and sexually transmitted infections (STI). We aimed to (1) identify subgroups of drug use during sex among MSM in Amsterdam and after classifying participants and (2) compare sexual behaviour and STI across groups. DESIGN: Cross-sectional study. Latent class analysis was used to identify subgroups with similar drug use patterns, between which sexual behaviour and STI prevalence were compared. SETTING: Four different studies conducted at the STI out-patient clinic in Amsterdam, the Netherlands, between January 2014 and June 2016. PARTICIPANTS: A total of 1130 self-declared MSM, aged ≥ 18 years. MEASUREMENTS: Self-reported drug use, laboratory-confirmed STI, socio-demographics, sexual behaviour (including number of partners), condom use. FINDINGS: Median age was 40 years [interquartile range (IQR) = 32-47]. We identified five latent classes of users, which we labelled: 'no substance' (n = 162), 'alcohol' (n = 159), 'nitrites and erectile dysfunction drugs (EDD)' (n = 286), 'polydrug' (n = 257) and 'chems' (n = 266). Median number of sex partners significantly differed across classes (P < 0.001), ranging from two (IQR = 1-6) in the 'no substance' class to 20 (IQR = 10-45) in the 'chems' class. The proportion of MSM reporting condomless anal sex also differed across classes (P < 0.001), ranging from 45.6% in the 'no substance' class to 86.5% in the 'chems' class. Compared with the 'no substance' class, the odds of STI were 3.9-fold [95% confidence interval (CI) = 1.1-14.4] higher in the 'alcohol' class, 8.9-fold (95% CI = 2.7-29.2) higher in the 'nitrites and EDD' class, 12.8-fold (95% CI = 3.9-41.9) higher in the 'polydrug' class and 15.0-fold (95% CI = 4.6-48.8) higher in the 'chems' class. CONCLUSION: There are five distinct classes of drug use in a sexual context among men who have sex with men in Amsterdam, the Netherlands. Classes with higher levels of drug use appear to coincide with higher levels of sexual risk behaviour and sexually transmitted infections.
Keywords:
Bacterial sexually transmitted infections; drug use behaviour; latent class analysis; men who have sex with men; sexual behaviour; substance use
Authors: Liza Coyer; Anders Boyd; Udi Davidovich; Ward P H van Bilsen; Maria Prins; Amy Matser Journal: Addiction Date: 2021-09-22 Impact factor: 7.256
Authors: Michael Viamonte; Delaram Ghanooni; John M Reynolds; Christian Grov; Adam W Carrico Journal: Curr HIV/AIDS Rep Date: 2022-06-14 Impact factor: 5.495
Authors: Cheríe S Blair; Jack Needleman; Marjan Javanbakht; W Scott Comulada; Amy Ragsdale; Robert Bolan; Steven Shoptaw; Pamina M Gorbach Journal: J Urban Health Date: 2022-01-14 Impact factor: 5.801
Authors: Rayner Kay Jin Tan; Caitlin Alsandria O'Hara; Wee Ling Koh; Daniel Le; Avin Tan; Adrian Tyler; Calvin Tan; Chronos Kwok; Sumita Banerjee; Mee Lian Wong Journal: BMC Public Health Date: 2021-05-31 Impact factor: 3.295
Authors: Rosibel Rodríguez-Bolaños; Ricardo Baruch-Dominguez; Edna Arillo-Santillán; Elsa Yunes-Díaz; Leonor Rivera-Rivera; Lizeth Cruz-Jiménez; James F Thrasher; Alan G Nyitray; Eduardo Lazcano-Ponce Journal: Int J Environ Res Public Health Date: 2022-07-21 Impact factor: 4.614
Authors: Y J Evers; C J P A Hoebe; N H T M Dukers-Muijrers; C J G Kampman; S Kuizenga-Wessel; D Shilue; N C M Bakker; S M A A Schamp; H Van Buel; W C J P M Van Der Meijden; G A F S Van Liere Journal: Prev Med Rep Date: 2020-03-06